Personalis, Inc. (PSNL) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
26/68
1.9 / 5 stars
All 68 Win/Lose results and 52 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinPSNL / S&P 110.36% / 15.20% |
LosePSNL / S&P -13.26% / 15.00% |
LosePSNL / S&P -11.38% / 50.40% |
| 2026-Q10/3 |
LosePSNL / S&P -19.97% / -4.33% |
LosePSNL / S&P -24.71% / 11.30% |
LosePSNL / S&P -17.74% / 27.70% |
| 2025-Q41/3 |
WinPSNL / S&P 22.09% / 2.65% |
LosePSNL / S&P -17.69% / 9.00% |
LosePSNL / S&P -31.06% / 13.40% |
| 2025-Q30/3 |
LosePSNL / S&P -0.61% / 8.12% |
LosePSNL / S&P -21.02% / 4.61% |
LosePSNL / S&P -50.60% / 13.45% |
| 2025-Q21/3 |
WinPSNL / S&P 86.89% / 10.94% |
LosePSNL / S&P 0.36% / 4.83% |
LosePSNL / S&P -25.00% / 10.63% |
| 2025-Q11/3 |
LosePSNL / S&P -39.27% / -4.27% |
WinPSNL / S&P 15.57% / 4.98% |
LosePSNL / S&P -34.74% / 10.57% |
| 2024-Q42/3 |
WinPSNL / S&P 7.43% / 2.41% |
WinPSNL / S&P 15.15% / 5.25% |
LosePSNL / S&P -41.33% / 6.15% |
| 2024-Q32/3 |
WinPSNL / S&P 359.83% / 5.89% |
WinPSNL / S&P 24.05% / 5.89% |
LosePSNL / S&P -29.41% / 6.11% |
| 2024-Q21/3 |
LosePSNL / S&P -21.48% / 4.28% |
WinPSNL / S&P 19.20% / 5.38% |
LosePSNL / S&P -30.51% / 5.12% |
| 2024-Q11/3 |
LosePSNL / S&P -29.05% / 10.56% |
WinPSNL / S&P 7.96% / 5.71% |
LosePSNL / S&P -22.76% / 5.59% |
| 2023-Q42/3 |
WinPSNL / S&P 73.55% / 11.69% |
WinPSNL / S&P 12.97% / 6.81% |
LosePSNL / S&P -9.27% / 7.78% |
| 2023-Q31/3 |
LosePSNL / S&P -35.64% / -3.27% |
LosePSNL / S&P 2.20% / 7.52% |
WinPSNL / S&P 4.85% / -5.03% |
| 2023-Q21/3 |
LosePSNL / S&P -31.88% / 8.74% |
LosePSNL / S&P -12.13% / 9.50% |
WinPSNL / S&P 12.92% / -8.57% |
| 2023-Q12/3 |
WinPSNL / S&P 39.39% / 7.50% |
LosePSNL / S&P -13.98% / 10.77% |
WinPSNL / S&P 34.43% / -15.69% |
| 2022-Q40/2 |
LosePSNL / S&P -33.33% / 7.56% |
LosePSNL / S&P -23.92% / 11.88% |
No dataPSNL / S&P / -17.99% |
| 2022-Q30/2 |
LosePSNL / S&P -13.91% / -4.88% |
LosePSNL / S&P -18.80% / 13.47% |
No dataPSNL / S&P / -1.41% |
| 2022-Q20/2 |
LosePSNL / S&P -57.88% / -16.10% |
LosePSNL / S&P -7.43% / 13.71% |
No dataPSNL / S&P / 11.04% |
| 2022-Q10/2 |
LosePSNL / S&P -42.61% / -4.60% |
LosePSNL / S&P -0.66% / 15.97% |
No dataPSNL / S&P / 42.23% |
| 2021-Q40/2 |
LosePSNL / S&P -25.83% / 11.03% |
LosePSNL / S&P 8.70% / 15.00% |
No dataPSNL / S&P / 96.40% |
| 2021-Q31/2 |
LosePSNL / S&P -23.95% / 0.58% |
WinPSNL / S&P 10.91% / 10.77% |
No dataPSNL / S&P / 69.42% |
| 2021-Q21/2 |
LosePSNL / S&P 2.80% / 8.55% |
WinPSNL / S&P 11.60% / 6.58% |
No dataPSNL / S&P / 51.81% |
| 2021-Q11/2 |
LosePSNL / S&P -32.78% / 6.17% |
WinPSNL / S&P 14.33% / -1.06% |
No dataPSNL / S&P / 7.39% |
| 2020-Q42/2 |
WinPSNL / S&P 68.94% / 12.15% |
WinPSNL / S&P 20.61% / -3.72% |
No dataPSNL / S&P / -33.42% |
| 2020-Q32/2 |
WinPSNL / S&P 67.08% / 8.93% |
WinPSNL / S&P 27.26% / -2.04% |
No dataPSNL / S&P / -27.10% |
| 2020-Q22/2 |
WinPSNL / S&P 60.72% / 20.54% |
WinPSNL / S&P 35.19% / -0.46% |
No dataPSNL / S&P / -27.11% |
| 2020-Q11/2 |
LosePSNL / S&P -25.96% / -19.60% |
WinPSNL / S&P 47.41% / 3.47% |
No dataPSNL / S&P / -14.75% |
| 2019-Q40/1 |
LosePSNL / S&P -25.72% / 9.07% |
No dataPSNL / S&P / 5.36% |
No dataPSNL / S&P / 2.99% |
| 2019-Q30/1 |
LosePSNL / S&P -45.95% / 1.70% |
No dataPSNL / S&P / 5.02% |
No dataPSNL / S&P / 0.21% |
| 2019-Q20/0 |
No dataPSNL / S&P / 4.30% |
No dataPSNL / S&P / 6.64% |
No dataPSNL / S&P / 8.65% |
| 2019-Q10/0 |
No dataPSNL / S&P / 13.65% |
No dataPSNL / S&P / 8.12% |
No dataPSNL / S&P / 14.29% |
| 2018-Q40/0 |
No dataPSNL / S&P / -13.52% |
No dataPSNL / S&P / 9.05% |
No dataPSNL / S&P / 18.23% |
| 2018-Q30/0 |
No dataPSNL / S&P / 7.71% |
No dataPSNL / S&P / 10.21% |
No dataPSNL / S&P / 19.06% |
| 2018-Q20/0 |
No dataPSNL / S&P / 3.43% |
No dataPSNL / S&P / 9.03% |
No dataPSNL / S&P / 14.46% |
| 2018-Q10/0 |
No dataPSNL / S&P / -0.76% |
No dataPSNL / S&P / 7.68% |
No dataPSNL / S&P / 12.46% |
| 2017-Q40/0 |
No dataPSNL / S&P / 6.64% |
No dataPSNL / S&P / 7.03% |
No dataPSNL / S&P / 13.82% |
| 2017-Q30/0 |
No dataPSNL / S&P / 4.48% |
No dataPSNL / S&P / 5.68% |
No dataPSNL / S&P / 17.57% |
| 2017-Q20/0 |
No dataPSNL / S&P / 3.09% |
No dataPSNL / S&P / 4.83% |
No dataPSNL / S&P / 17.74% |
| 2017-Q10/0 |
No dataPSNL / S&P / 6.07% |
No dataPSNL / S&P / 3.67% |
No dataPSNL / S&P / 13.32% |
| 2016-Q40/0 |
No dataPSNL / S&P / 3.82% |
No dataPSNL / S&P / 2.09% |
No dataPSNL / S&P / 7.05% |
| 2016-Q30/0 |
No dataPSNL / S&P / 3.85% |
No dataPSNL / S&P / 0.20% |
No dataPSNL / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PSNL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 243.56% | 20.78% |
| Annualized return | 243.56% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PSNL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -23.25% | 83.14% |
| Annualized return | -5.16% | 12.86% |
10Y · 2019-06-20 to 2026-08-27
| Metric | PSNL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -41.03% | 319.30% |
| Annualized return | -5.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |